查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576642

微阵列试剂盒市场：产品类型、应用、最终用户- 2031 年世界预测

Microarray Kits Market by Product Type (DNA [cDNA, Oligo, BAC, SNP], RNA, Protein, Tissue), Application (Drug Discovery & Development, Research, Diagnostic), End User (CRO, Pharma & Biotech, Academic, Hospital & Diagnostic Lab) - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 220 Pages | 商品交期: 5-7个工作天内

价格

该报告基于全面的一手和二手研究以及对市场情景的深入分析，提供了该行业的关键推动因素、限制、课题和机会。该市场的推动因素包括微阵列研究应用的增加、微阵列在癌症研究中的使用、个人化医疗的日益采用以及製药和生物技术行业研发支出的增加。

此外，微阵列技术和新兴国家的技术进步正在为该市场创造巨大的成长机会。然而，与其他遗传方法相比，微阵列的高成本可能会限制该市场的成长。此外，缺乏敏感性和准确性给在该市场运营的公司带来了重大课题。

目录

第1章简介

第2章 研究方法

第3章 执行摘要

第4章 市场洞察

  • 概述
  • 促进因素
    • 在研究中越来越多地使用微阵列
    • 微阵列在癌症研究的应用
    • 个人化医疗的普及
    • 製药和生技产业的研发费用不断增加
  • 阻碍因素
    • 与其他基因检测方法相比，微阵列的成本较高
  • 机会
    • 微阵列技术的进展
    • 新兴经济体
  • 任务
    • 缺乏灵敏度和准确性
  • 趋势
  • 监管场景
  • 价格分析
  • 价值链分析

第5章全球微阵列试剂盒市场：依产品类型

  • 概述
  • DNA 微阵列试剂盒
    • cDNA 微阵列试剂盒
    • 寡核甘酸微阵列试剂盒
    • BAC 微阵列晶片试剂盒
    • SNP 微阵列试剂盒
  • RNA 微阵列试剂盒
  • 蛋白质微阵列试剂盒
  • 组织微阵列试剂盒

第6章全球微阵列试剂盒市场：依应用分类

  • 概述
  • 药物发现/药物开发
  • 研究用途
  • 诊断
  • 其他用途

第7章全球微阵列试剂盒市场：依最终用户分类

  • 概述
  • 製药和生物技术公司
  • CRO（合同研究组织）
  • 研究和学术机构
  • 医院/诊断实验室
  • 其他最终使用者（兽医院、农业、法医实验室）

第8章 微阵列试剂盒市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东/非洲

第9章 竞争分析

  • 概述
  • 主要成长策略
  • 竞争标桿
  • 比赛仪表板
    • 市场领导者
    • 差异化因素
    • 先锋公司
    • 启动
  • 主要企业市占率分析/市场排名（2022年）

第10章 公司简介（公司概况、财务概况、产品组合、策略发展现况）

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Merck KgaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Edvotek Inc.
  • Sakura Finetek USA, Inc.
  • Dextra Laboratories Ltd
  • GeneCopoeia, Inc.
  • 其他公司

（註：将提供前5名企业的SWOT分析）

第11章附录

Product Code: MRHC - 1041094

The microarray kits market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the increasing research applications of microarrays, the use of microarrays in cancer research, the increasing adoption of personalized medicine, and the growing R&D expenditure in the pharmaceutical and biotechnology industries.

Furthermore, technological advancements in microarray technology and emerging economies provide a significant growth opportunity for this market. However, the higher costs of microarrays, as compared to other genetic methods, may restrain the growth of this market. Additionally, lack of sensitivity and accuracy pose a major challenge for the players operating in this market.

Among product type, in 2024, the DNA microarray kits segment is expected to account for the largest share of the market. DNA microarrays, also known as DNA chips or gene chips, are used in genomics and molecular biology for the simultaneous analysis of thousands to millions of DNA sequences, typically genes or oligonucleotide probes, on a small, solid support surface. The large market share of the segment is attributed to factors such as increasing incidence of cancer, wide application areas of microarray technology, rising funding for genomic R&D, and growing research for personalized medicine.

Among applications, in 2024, the drug discovery & development segment is expected to account for the largest share of the market. Drug discovery & development include the experiments that are conducted to test certain drugs or theories that can be applied to a particular disease treatment. The large market share of the segment is attributed to factors such as growing R&D expenditure, a large number of academic and research institutes focusing on cancer research, and growing innovations in the field of microarray technology.

Among end users, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market. Pharmaceutical and biotechnology companies use microarray kits and technology for various applications such as drug discovery, cancer biomarker detection, and personalized medicines. The large share of the market is attributed to factors such as a growing focus on drug discovery & development, and rising pharmaceutical R&D expenditure, and increased adoption of personalized medicines. In the case of personalized medicine, DNA microarray kits can be used to compare diseased tissues/cells with healthy tissues/cells in order to find the characteristics of a disease. In the case of drug discovery & development, protein microarray kits are used to screen patients and then prescribe drugs to exclude potential side effects and determine the most suitable dose, hence driving the growth of the segment.

An in-depth analysis of the geographical scenario of the global microarray kits market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the global microarray kits market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The largest share of the segment is primarily due to the availability of advanced infrastructure for genomic research, the presence of key players, the presence of key pharmaceutical companies and research institutes, availability of funding for life science research. The presence of key players in the market improves the accessibility to advanced microarray technology resources, including kits.

The key players operating in the global microarray kits market are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).

Scope of the Report:

Microarray Kits Market-by Product Type

  • DNA Microarray Kits
    • cDNA Microarray Kits
    • Oligo Microarray Kits
    • BAC Microarray Kits
    • SNP Microarray Kits
  • RNA Microarray Kits
  • Protein Microarray Kits
  • Tissue Microarray Kits

Microarray Kits Market-by Application

  • Drug Discovery & Development
  • Research Applications
  • Diagnostics
  • Other Applications

(Other applications primarily include agriculture, food & beverages, and forensics)

Microarray Kits Market-by End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research & Academic Institutes
  • Hospitals & Diagnostic Laboratories
  • Other End Users

(Other end users primarily include veterinary clinics, agricultural industry, and forensic laboratories)

Microarray Kits Market-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Research Applications of Microarrays
    • 4.2.2. Use of Microarrays in Cancer Research
    • 4.2.3. Increasing Adoption of Personalized Medicine
    • 4.2.4. Growing R&D Expenditure in Pharmaceutical and Biotechnology Industries
  • 4.3. Restraints
    • 4.3.1. Higher Costs of Microarrays as Compared to Other Genetic Testing Methods
  • 4.4. Opportunities
    • 4.4.1. Technological Advancements in Microarray Technology
    • 4.4.2. Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Lack of Sensitivity and Accuracy
  • 4.6. Trends
  • 4.7. Regulatory Scenario
  • 4.8. Pricing Analysis
  • 4.9. Value Chain Analysis

5. Global Microarray Kits Market-by Product Type

  • 5.1. Overview
  • 5.2. DNA Microarray Kits
    • 5.2.1. cDNA Microarray Kits
    • 5.2.2. Oligo Microarray Kits
    • 5.2.3. BAC Microarray Kits
    • 5.2.4. SNP Microarray Kits
  • 5.3. RNA Microarray Kits
  • 5.4. Protein Microarray Kits
  • 5.5. Tissue Microarray Kits

6. Global Microarray Kits Market-by Application

  • 6.1. Overview
  • 6.2. Drug Discovery & Development
  • 6.3. Research Applications
  • 6.4. Diagnostics
  • 6.5. Other Applications

7. Global Microarray Kits Market-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biotechnology Companies
  • 7.3. Contract Research Organizations
  • 7.4. Research & Academic Institutes
  • 7.5. Hospitals & Diagnostic Laboratories
  • 7.6. Other End Users (Veterinary Clinics, Agricultural Industry, Forensic Laboratories)

8. Microarray Kits Market-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Rest of Asia Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Market Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis/Market Ranking, By Key Players (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Thermo Fisher Scientific, Inc.
  • 10.2. Illumina, Inc.
  • 10.3. Agilent Technologies, Inc.
  • 10.4. Merck KgaA
  • 10.5. PerkinElmer, Inc.
  • 10.6. QIAGEN N.V.
  • 10.7. Edvotek Inc.
  • 10.8. Sakura Finetek USA, Inc.
  • 10.9. Dextra Laboratories Ltd
  • 10.10. GeneCopoeia, Inc.
  • 10.11. Other Companies

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1 Global Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 2 Global DNA Microarray Kits Market, by Type, 2022-2031 (USD Million)
  • Table 3 Global DNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global cDNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Oligo Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global BAC Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global SNP Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global RNA Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Protein Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Tissue Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 12 Global Microarray Kits Market for Drug Discovery & Development, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Microarray Kits Market for Research Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Microarray Kits Market for Diagnostics, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Microarray Kits Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 17 Global Microarray Kits Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Microarray Kits Market for Contract Research Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Microarray Kits Market for Research & Academic Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Microarray Kits Market for Hospital & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Microarray Kits Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 North America: Microarray Kits Market, by Country, 2022-2031 (USD Million)
  • Table 24 North America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 25 North America: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 26 North America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 27 North America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 28 U.S.: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 29 U.S.: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 30 U.S.: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 31 U.S.: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 32 Canada: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 33 Canada: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 34 Canada: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 35 Canada: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 36 Europe: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Europe: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 38 Europe: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 39 Europe: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 40 Europe: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 41 Germany: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 42 Germany: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 43 Germany: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 44 Germany: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 45 France: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 46 France: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 47 France: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 48 France: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 49 U.K.: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 50 U.K.: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 51 U.K.: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 52 U.K.: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 53 Italy: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 54 Italy: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 55 Italy: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 56 Italy: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 57 Spain: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 58 Spain: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 59 Spain: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 60 Spain: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 61 Rest of Europe: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 62 Rest of Europe: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 63 Rest of Europe: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 64 Rest of Europe: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 65 Asia-Pacific: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 66 Asia-Pacific: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 67 Asia-Pacific: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 68 Asia-Pacific: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 69 Asia-Pacific: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 70 Japan: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 71 Japan: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 72 Japan: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 73 Japan: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 74 China: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 75 China: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 76 China: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 77 China: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 78 India: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 79 India: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 80 India: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 81 India: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 82 Rest of Asia-Pacific: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 83 Rest of Asia-Pacific: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 84 Rest of Asia-Pacific: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 85 Rest of Asia-Pacific: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 86 Latin America: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 87 Latin America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 88 Latin America: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 89 Latin America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 90 Latin America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 91 Brazil: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 92 Brazil: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 93 Brazil: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 94 Brazil: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 95 Mexico: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 96 Mexico: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 97 Mexico: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 98 Mexico: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 99 Rest of Latin America: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 100 Rest of Latin America: DNA Microarrays Market, by Type, 2022-2031 (USD Million)
  • Table 101 Rest of Latin America: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 102 Rest of Latin America: Microarray Kits Market, by End User, 2022-2031 (USD Million)
  • Table 103 Middle East & Africa: Microarray Kits Market, by Country/Region, 2022-2031 (USD Million)
  • Table 104 Middle East & Africa: Microarray Kits Market, by Product Type, 2022-2031 (USD Million)
  • Table 105 Middle East & Africa: DNA Microarray Market, by Type, 2022-2031 (USD Million)
  • Table 106 Middle East & Africa: Microarray Kits Market, by Application, 2022-2031 (USD Million)
  • Table 107 Middle East & Africa: Microarray Kits Market, by End User, 2022-2031 (USD Million)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Microarray Kits Market, by Applications, 2024 VS. 2031 (USD Million)
  • Figure 10 Microarray Kits Market, by Geography
  • Figure 11 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 13 Global Microarray Kits Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Microarray Kits Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 15 North America: Microarray Kits Market Snapshot
  • Figure 16 Europe: Microarray Kits Market Snapshot
  • Figure 17 Asia-Pacific: Microarray Kits Market Snapshot
  • Figure 18 Latin America: Microarray Kits Market Snapshot
  • Figure 19 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 20 Global Microarray Kits Market: Competitive Dashboard
  • Figure 21 Global Microarray Kits Market: Competitive Benchmarking, by Product Type
  • Figure 22 Global Microarray Kits Market: Market Share Analysis/Market Ranking (2024)
  • Figure 23 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
  • Figure 24 Illumina, Inc.: Financial Overview (2022)
  • Figure 25 Agilent Technologies, Inc.: Financial Overview (2024)
  • Figure 26 Merck KGaA: Financial Overview (2022)
  • Figure 27 PerkinElmer, Inc.: Financial Overview (2022)
  • Figure 28 QIAGEN N.V.: Financial Overview (2022)